A case report of acute hypothermia during initial inpatient clozapine titration with review of current literature on clozapine-induced temperature dysregulations

BMC Psychiatry
Bradley G BurkBrooke Clark

Abstract

Here we describe a unique case of clozapine-associated hypothermia during initial titration of this medication in an acute inpatient psychiatry setting. Only a handful of cases on this topic have been published. We discuss possible pharmacologic mechanisms supporting or refuting the propensity of clozapine to induce hypothermia, as well as risk factors for clozapine-induced hypothermia, and a comparison to clozapine-induced hyperthermia. A 70 year-old African American female with treatment-refractory schizoaffective disorder developed hypothermia with a nadir temperature of 89 °F (31.7 °C) after 7 days on clozapine, on a total dose of 50 mg twice daily. Accompanying symptoms included bradycardia, hypotension, QTc prolongation, tachypnea, hypoxemia, and an absence of shivering. The patient was transferred to the ICU, and rewarmed within 10 h with the discontinuation of her clozapine, ziprasidone, and carvedilol. Broad spectrum antibiotics were initiated, but discontinued shortly after, as the patient had no leukocytosis, and blood cultures were negative. While hypoglycemia, hypothyroidism, sepsis, and stroke were effectively ruled out, alternative drug-disease (including chronic kidney disease), and drug-drug interactions were c...Continue Reading

References

Apr 1, 1987·British Journal of Pharmacology·G BoschiR Rips
May 1, 1988·Acta Physiologica Scandinavica·S O Ogren, K Fuxe
Jan 1, 1982·Annals of the New York Academy of Sciences·A J Prange, C B Nemeroff
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Jul 4, 1995·European Journal of Pharmacology·M J MillanA Newman-Tancredi
Feb 21, 1994·European Journal of Pharmacology·P SalmiS Ahlenius
Dec 29, 1994·The New England Journal of Medicine·D F Danzl, R S Pozos
Oct 1, 1995·Pharmacology, Biochemistry, and Behavior·A F Abdel-FattahH Watanabe
Feb 23, 2000·Neuroreport·S PerachonP Sokoloff
Sep 15, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·C E BlackC Y Pang
Nov 28, 2002·QJM : Monthly Journal of the Association of Physicians·M L Mallet
Jul 17, 2003·The Journal of Emergency Medicine·Lyle Thomas, P Timothy Pollak
Oct 1, 1954·Anaesthesia·J W DUNDEEW E SCOTT
Apr 3, 2007·European Journal of Clinical Pharmacology·Rob J van MarumErna Beers
Sep 6, 2007·The Annals of Pharmacotherapy·Carolina Molina LoweAnn C Scates
Sep 29, 2007·Psychiatrische Praxis·Stefan LöfflerAnsgar Klimke
Dec 18, 2008·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Joseph Pui-yin ChungWah-fat Chan
Jan 8, 2009·The Annals of Pharmacotherapy·Izchak KohenPeter Manu
Jun 11, 2009·Journal of Clinical Psychopharmacology·Georgios PapazisisDimitrios Kouvelas
Jun 15, 2010·Current Drug Metabolism·J J SheehanC M Canuso
Jul 6, 2010·Neuroscience Letters·Peter B HedlundRoberto Perrone
Oct 1, 2011·Journal of Clinical Pharmacology·Peter KreuzerBerthold Langguth
Oct 30, 2012·International Clinical Psychopharmacology·Anto P RajkumarKuruthukulangara S Jacob
Dec 20, 2012·The Primary Care Companion to CNS Disorders·Roopa Sethi, Bush Kavuru
Jan 1, 2011·The Neurohospitalist·Brian D Berman
Dec 3, 2014·Seminars in Fetal & Neonatal Medicine·Thomas Wood, Marianne Thoresen
Jul 15, 2015·Clinical Neuropharmacology·Valentina BrunoOscar Alcoverro
Feb 26, 2016·Behavioural Brain Research·Chelsea A VadnieDoo-Sup Choi
Oct 27, 2016·Hellenic Journal of Cardiology : HJC = Hellēnikē Kardiologikē Epitheōrēsē·Eleftherios PelechasChristoforos Kardamis
Jan 21, 2017·Psychiatry and Clinical Neurosciences·Yuan-Pin HungTzu-Yun Wang
Sep 25, 2017·Frontiers in Psychiatry·Cherryl ZonnenbergJan Dirk Blom
Oct 19, 2017·Journal of Clinical Psychopharmacology·Thomas A ScherlPeter M Kreuzer
Jan 13, 2018·The Primary Care Companion to CNS Disorders·Michael R WareKaren L Hall
Apr 6, 2018·Journal of Clinical Psychopharmacology·Leif HommersStefan Unterecker
Nov 7, 2018·International Clinical Psychopharmacology·Anna M Szota, Aleksander S Araszkiewicz
Nov 10, 2018·European Journal of Pharmacology·Tyler J Murphy, Kevin S Murnane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.